ClinVar Miner

Submissions for variant NM_152296.5(ATP1A3):c.2677G>C (p.Gly893Arg) (rs1568853466)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000705732 SCV000834745 likely pathogenic Dystonia 12 2018-06-22 criteria provided, single submitter clinical testing This sequence change replaces glycine with arginine at codon 893 of the ATP1A3 protein (p.Gly893Arg). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and arginine. This variant is not present in population databases (ExAC no frequency). This variant has been observed to be de novo in individuals affected with Dystonia (Invitae). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). A different nucleotide substitution (c.2677G>A) resulting in the same amino acid change at this codon (p.Gly893Arg) has been reported as de novo in an individual affected with alternating hemiplegia of childhood (PMID: 24842602). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.